Clene (CLNN) director granted 2,816 stock options at $7.30

Clene Inc. (CLNN) reported a stock-based compensation award to one of its directors.

Accepted by SEC EDGAR 11/14/2025 - 04:45 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Clene Inc. (CLNN) reported a stock-based compensation award to one of its directors. On November 13, 2025, the director received a stock option covering 2,816 shares of Clene common stock under the company’s Amended 2020 Stock Plan. The option has an exercise price of $7.30 per share and vests immediately, meaning the director can exercise it right away, subject to plan terms. The option is scheduled to expire on November 12, 2035 if not exercised.

Insider Trade Summary

Grant/Award: 2,816 shares

Grant/Award 1 txn

Insider Jacobovitz Shalom

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	2,816	$0.00	$0.00

Holdings After Transaction: stock option — 2,816 contracts (Direct)

Footnotes (1)

1. F1. This option was granted on November 13, 2025 as an option for 2,816 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Clene Inc. (CLNN) report in this Form 4?

Clene Inc. reported that a director was granted a stock option for 2,816 shares of common stock under the Amended 2020 Stock Plan.

What is the exercise price of the Clene (CLNN) director stock option?

The director stock option has an exercise price of $7.30 per share for Clene common stock.

When was the Clene (CLNN) director stock option granted and when does it expire?

The option was granted on November 13, 2025 and is scheduled to expire on November 12, 2035 if not exercised.

How many Clene (CLNN) shares are underlying the reported stock option?

The reported stock option covers 2,816 shares of Clene Inc. common stock.

When do the Clene (CLNN) director stock options vest?

The stock options vest immediately upon grant, according to the disclosure.

Is this Clene (CLNN) Form 4 filed for one reporting person or a group?

The Form 4 is indicated as being filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jacobovitz Shalom

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UT 84121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$7.3	11/13/2025		A		2,816		(1)	11/12/2035	common stock	2,816	$0	2,816	D

Explanation of Responses:

1. This option was granted on November 13, 2025 as an option for 2,816 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $7.30 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	11/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.